Biden’s FDA Pick Califf to Face Senate Queries on Industry Ties

December 13, 2021, 10:05 AM UTC

President Joe Biden’s pick to lead the FDA will face questions on his longstanding ties to the pharmaceutical industry and the agency’s role in combating the Covid-19 pandemic at a key confirmation hearing Tuesday.

Robert Califf, who previously led the Food and Drug Administration in the final year of the Obama administration, will outline his qualifications at a Senate Health, Education, Labor, and Pensions Committee hearing—a crucial step in his path toward reassuming the reins of the agency.

Former FDA officials say widespread respect for Califf within the agency and across the drug industry can help push him across the ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.